---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-051841"
form_type: "8-K"
ticker: "HOOK"
cik: "0001760542"
company_name: "HOOKIPA Pharma Inc."
filed_at: "2025-05-22T23:59:59+00:00"
generated_at: "2026-05-20T18:34:02.260087+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# HOOKIPA to sell HB-400/HB-500 assets to Gilead for up to $10M; board approves dissolution

## Summary
- Gilead to acquire HB-400 and HB-500 assets for up to $10M in cash; $3M at closing, up to $7M in transfer completion payments.
- Board approved dissolution of HOOKIPA; filing of Certificate of Dissolution expected after Transfer Plan completion.
- Asset sale and dissolution require stockholder approval; proxy statement to be filed for special meeting.
- CEO Malte Peters receives severance, accelerated equity vesting, and a Special Dissolution Success Bonus up to €482,591.
- Collaboration Agreement and Stock Purchase Agreement with Gilead will terminate at closing.

## SEC filing metadata
- accession: 0001104659-25-051841
- form_type: 8-K
- ticker: HOOK
- cik: 0001760542
- company_name: HOOKIPA Pharma Inc.
- filed_at: 2025-05-22T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 1.01, 1.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1760542/000110465925051841/0001104659-25-051841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1760542/000110465925051841/tm2515845d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-051841
- JSON: https://secwatch.observer/filing/0001104659-25-051841.json
- Plain text: https://secwatch.observer/filing/0001104659-25-051841.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.